July 7 - Kalvista’s delayed OK, Apogee’s Dupixent competitor and Cogent’s catalyst
 
 

Daily Dive

July​ 7,​ 2025 | Today’s news and insights for biopharma leaders
 
 
 
 
 
 
 
 

 

 

 

 
Read more news
 
 

From Our Library